← Leaderboards
Navnath S Gavande
Indiana University Indianapolis
$1,444,425
Attributed
$2,888,849
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $603.6K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,888,849 · 1
By mechanism
R01$2,888,849 · 1
Top collaborators
- John J Turchi5 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Elliot J Androphy$24,340,128
- Reuben Kapur$21,257,649
- Ravi Prakash Sahu$1,257,866
- David W. Clapp$30,065,006
- Randal J. Kaufman$37,816,764
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentActive SitesAnti-Cancer TherapeuticAntineoplastic AgentsAutomobile DrivingAnti-CancerBindingBiochemicalBiological AvailabilityBleomycinBrca1 GeneBrca2 GeneCancer CellCancer GeneticsCancer ModelCancer TherapyCellsCharacteristicsChemistryChemotherapy And/Or RadiationCisplatinClinically RelevantCombined Modality TherapyCoupled
Grant awards (5)
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition$555,248
R01 · FY2024 · CA
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition$572,781
R01 · FY2023 · CA
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition$572,781
R01 · FY2022 · CA
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition$584,470
R01 · FY2021 · CA
Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition$603,569
R01 · FY2020 · CA